BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update.

By María E. Reig1 , 2, Alejandro Forner1 , 2, J. Rimola, J. Ferrer-Fábrega, M. Burrel, Á. García-Criado, R. Kelley, Peter R. Galle, V. Mazzaferro, R. Salem and 6 more. Journal of Hepatology, 2021

2,982 citations recorded by the source corpus.

Treatment for hepatocellular carcinoma (HCC) has experienced major advancements since the last update of the official Barcelona Clinic Liver Cancer (BCLC) prognosis and treatment strategy published in 2018. Advancements in the field have emerged in all areas, but in this manuscript, we present those that have primed a change in the strategy and comment why some encouraging data in select interventions are still considered immature and in need of further research to gain their incorporation into an evidence-based model for clinicians and researchers. Finally, we describe the critical insight and expert knowledge that is needed to take clinical decisions in individual patients so that the recommendation takes into account all the needed parameters to allow a personalised approach.

Subfields: Hepatology, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/f62ac06907a7ba4dd7789ecdfa41ae29e9296773

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

  1. Amit G. Singal
  2. F. Kanwal
  3. J. Llovet
  4. Jordi Bruix1 , 2
  5. Riccardo Lencioni

In Oncology

  1. J. Llovet

Citations in the corpus